South East Asia Pranlukast Market Size & Outlook, 2026-2034


South East Asia Pranlukast Market Insights

  • As per Reed Intelligence insights, the South East Asia Pranlukast Market stood at USD 13.43 Billion in 2025 and is anticipated to grow to USD 28.55 Billion by 2034.
  • The South East Asia market is expected to advance at a CAGR of 8.74% from 2026 through 2034.
  • In 2025, Tablets accounted for the highest share of the Formulation Type market size.
  • During the forecast period, Oral Suspensions is set to register the highest growth, making it the most lucrative Formulation Type segment.

Other Key Findings


  • In 2025, South East Asia accounted for 1.81% of the global Pranlukast Market size.
  • By 2034, United States is expected to lead the global Pranlukast Market in terms of market size.
  • Within Asia Pacific, China is projected to dominate the regional Pranlukast Market size by 2034.
  • Taiwan is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 15.13 Billion by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 13.43 Billion
Market Size In 2034 USD 28.55 Billion
Largest segment Tablets
Units Revenue in USD Billion
CAGR 8.74% (2026-2034)
Segmnetation Covered
Formulation Type
  1. Tablets
  2. Capsules
  3. Oral Suspensions
  4. Others
Application
  1. Asthma Treatment
  2. Allergic Rhinitis Treatment
  3. Bronchitis Management
  4. Others
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Drug Stores
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends